The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey
This real-world study expands our understanding of the patient journey for patients with PPF and IPF in Japan. Greater communication between patients and physicians is needed to shorten diagnostic delays and target treatment strategies to improve patient experience and overall outcomes.
Authors
- M. Okazaki (ORCID: https://orcid.org/0000-0001-5455-2909)
- Yuko Waseda (ORCID: https://orcid.org/0000-0002-7120-8517)
- Yuko Kaneko (ORCID: https://orcid.org/0000-0003-2646-5765)
- Hidekata Yasuoka (ORCID: https://orcid.org/0000-0002-2405-6282)
- Ryoko Iwasaki
- Haruyuki Ishii (ORCID: https://orcid.org/0000-0002-9435-9246)
- Mark Small (ORCID: https://orcid.org/0000-0003-3240-5283)
- Shoko Nagata
Institutions
- Fujita Health University (JP)
- Kyorin University (JP)
- Keio University (JP)
- Adelphi Group (United Kingdom) (GB)
- University of Fukui Hospital (JP)
- Boehringer Ingelheim (Japan) (JP)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-04-11
- DOI
- https://doi.org/10.3389/fmed.2025.1526530
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00